nodes	percent_of_prediction	percent_of_DWPC	metapath
Sildenafil—ABCC10—Gemcitabine—pancreatic cancer	0.0973	0.128	CbGbCtD
Sildenafil—ABCC5—Fluorouracil—pancreatic cancer	0.0832	0.11	CbGbCtD
Sildenafil—ABCC10—Docetaxel—pancreatic cancer	0.0636	0.0838	CbGbCtD
Sildenafil—ABCC10—Doxorubicin—pancreatic cancer	0.0474	0.0625	CbGbCtD
Sildenafil—ABCC4—Fluorouracil—pancreatic cancer	0.04	0.0527	CbGbCtD
Sildenafil—CYP1A1—Dacarbazine—pancreatic cancer	0.0339	0.0447	CbGbCtD
Sildenafil—ABCC4—Sunitinib—pancreatic cancer	0.0304	0.0401	CbGbCtD
Sildenafil—CYP1A1—Tamoxifen—pancreatic cancer	0.0269	0.0355	CbGbCtD
Sildenafil—CYP2E1—Dacarbazine—pancreatic cancer	0.0262	0.0345	CbGbCtD
Sildenafil—CYP1A1—Erlotinib—pancreatic cancer	0.0229	0.0302	CbGbCtD
Sildenafil—CYP3A7—Tamoxifen—pancreatic cancer	0.0216	0.0284	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Tamoxifen—pancreatic cancer	0.0216	0.0284	CbGbCtD
Sildenafil—CYP2E1—Tamoxifen—pancreatic cancer	0.0208	0.0274	CbGbCtD
Sildenafil—CYP3A7—Irinotecan—pancreatic cancer	0.0166	0.0218	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Irinotecan—pancreatic cancer	0.0166	0.0218	CbGbCtD
Sildenafil—CYP3A5—Tamoxifen—pancreatic cancer	0.0162	0.0213	CbGbCtD
Sildenafil—CYP3A5—Erlotinib—pancreatic cancer	0.0137	0.0181	CbGbCtD
Sildenafil—CYP2C19—Tamoxifen—pancreatic cancer	0.013	0.0172	CbGbCtD
Sildenafil—CYP3A5—Irinotecan—pancreatic cancer	0.0124	0.0164	CbGbCtD
Sildenafil—CYP3A7—Docetaxel—pancreatic cancer	0.0121	0.016	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Docetaxel—pancreatic cancer	0.0121	0.016	CbGbCtD
Sildenafil—CYP3A7-CYP3A51P—Sunitinib—pancreatic cancer	0.0121	0.0159	CbGbCtD
Sildenafil—CYP3A7—Sunitinib—pancreatic cancer	0.0121	0.0159	CbGbCtD
Sildenafil—CYP2C9—Tamoxifen—pancreatic cancer	0.0108	0.0143	CbGbCtD
Sildenafil—CYP2D6—Tamoxifen—pancreatic cancer	0.00992	0.0131	CbGbCtD
Sildenafil—CYP3A5—Docetaxel—pancreatic cancer	0.0091	0.012	CbGbCtD
Sildenafil—CYP3A5—Sunitinib—pancreatic cancer	0.00906	0.0119	CbGbCtD
Sildenafil—CYP2D6—Erlotinib—pancreatic cancer	0.00843	0.0111	CbGbCtD
Sildenafil—CYP2C9—Fluorouracil—pancreatic cancer	0.00799	0.0105	CbGbCtD
Sildenafil—CYP3A4—Tamoxifen—pancreatic cancer	0.00631	0.00832	CbGbCtD
Sildenafil—CYP3A4—Erlotinib—pancreatic cancer	0.00536	0.00707	CbGbCtD
Sildenafil—CYP3A4—Irinotecan—pancreatic cancer	0.00484	0.00639	CbGbCtD
Sildenafil—CYP2D6—Doxorubicin—pancreatic cancer	0.00416	0.00549	CbGbCtD
Sildenafil—CYP3A4—Docetaxel—pancreatic cancer	0.00355	0.00468	CbGbCtD
Sildenafil—CYP3A4—Sunitinib—pancreatic cancer	0.00353	0.00466	CbGbCtD
Sildenafil—CYP3A4—Doxorubicin—pancreatic cancer	0.00265	0.00349	CbGbCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	8.71e-05	0.000429	CcSEcCtD
Sildenafil—Stomatitis—Epirubicin—pancreatic cancer	8.67e-05	0.000427	CcSEcCtD
Sildenafil—Conjunctivitis—Epirubicin—pancreatic cancer	8.64e-05	0.000426	CcSEcCtD
Sildenafil—Urinary tract infection—Epirubicin—pancreatic cancer	8.64e-05	0.000426	CcSEcCtD
Sildenafil—Hypersensitivity—Fluorouracil—pancreatic cancer	8.58e-05	0.000423	CcSEcCtD
Sildenafil—Dry mouth—Docetaxel—pancreatic cancer	8.58e-05	0.000422	CcSEcCtD
Sildenafil—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	8.58e-05	0.000422	CcSEcCtD
Sildenafil—Sweating—Epirubicin—pancreatic cancer	8.52e-05	0.00042	CcSEcCtD
Sildenafil—Pollakiuria—Doxorubicin—pancreatic cancer	8.52e-05	0.00042	CcSEcCtD
Sildenafil—Asthenia—Gemcitabine—pancreatic cancer	8.5e-05	0.000419	CcSEcCtD
Sildenafil—Haematuria—Epirubicin—pancreatic cancer	8.48e-05	0.000417	CcSEcCtD
Sildenafil—Photosensitivity reaction—Doxorubicin—pancreatic cancer	8.42e-05	0.000415	CcSEcCtD
Sildenafil—Oedema—Docetaxel—pancreatic cancer	8.41e-05	0.000414	CcSEcCtD
Sildenafil—Weight increased—Doxorubicin—pancreatic cancer	8.4e-05	0.000413	CcSEcCtD
Sildenafil—Epistaxis—Epirubicin—pancreatic cancer	8.39e-05	0.000413	CcSEcCtD
Sildenafil—Pruritus—Gemcitabine—pancreatic cancer	8.38e-05	0.000413	CcSEcCtD
Sildenafil—Infection—Docetaxel—pancreatic cancer	8.35e-05	0.000411	CcSEcCtD
Sildenafil—Sinusitis—Epirubicin—pancreatic cancer	8.34e-05	0.000411	CcSEcCtD
Sildenafil—Hyperglycaemia—Doxorubicin—pancreatic cancer	8.32e-05	0.00041	CcSEcCtD
Sildenafil—Diarrhoea—Irinotecan—pancreatic cancer	8.32e-05	0.00041	CcSEcCtD
Sildenafil—Pneumonia—Doxorubicin—pancreatic cancer	8.27e-05	0.000407	CcSEcCtD
Sildenafil—Shock—Docetaxel—pancreatic cancer	8.27e-05	0.000407	CcSEcCtD
Sildenafil—Nervous system disorder—Docetaxel—pancreatic cancer	8.24e-05	0.000406	CcSEcCtD
Sildenafil—Pruritus—Fluorouracil—pancreatic cancer	8.24e-05	0.000406	CcSEcCtD
Sildenafil—Infestation NOS—Doxorubicin—pancreatic cancer	8.23e-05	0.000405	CcSEcCtD
Sildenafil—Infestation—Doxorubicin—pancreatic cancer	8.23e-05	0.000405	CcSEcCtD
Sildenafil—Tachycardia—Docetaxel—pancreatic cancer	8.21e-05	0.000404	CcSEcCtD
Sildenafil—Skin disorder—Docetaxel—pancreatic cancer	8.17e-05	0.000402	CcSEcCtD
Sildenafil—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	8.16e-05	0.000402	CcSEcCtD
Sildenafil—Diarrhoea—Gemcitabine—pancreatic cancer	8.11e-05	0.000399	CcSEcCtD
Sildenafil—Renal failure—Doxorubicin—pancreatic cancer	8.09e-05	0.000398	CcSEcCtD
Sildenafil—Neuropathy peripheral—Doxorubicin—pancreatic cancer	8.06e-05	0.000397	CcSEcCtD
Sildenafil—Dizziness—Irinotecan—pancreatic cancer	8.04e-05	0.000396	CcSEcCtD
Sildenafil—Haemoglobin—Epirubicin—pancreatic cancer	8.02e-05	0.000395	CcSEcCtD
Sildenafil—Stomatitis—Doxorubicin—pancreatic cancer	8.02e-05	0.000395	CcSEcCtD
Sildenafil—Anorexia—Docetaxel—pancreatic cancer	8.01e-05	0.000395	CcSEcCtD
Sildenafil—Rhinitis—Epirubicin—pancreatic cancer	8e-05	0.000394	CcSEcCtD
Sildenafil—Conjunctivitis—Doxorubicin—pancreatic cancer	8e-05	0.000394	CcSEcCtD
Sildenafil—Urinary tract infection—Doxorubicin—pancreatic cancer	8e-05	0.000394	CcSEcCtD
Sildenafil—Haemorrhage—Epirubicin—pancreatic cancer	7.98e-05	0.000393	CcSEcCtD
Sildenafil—Diarrhoea—Fluorouracil—pancreatic cancer	7.97e-05	0.000392	CcSEcCtD
Sildenafil—Hypoaesthesia—Epirubicin—pancreatic cancer	7.94e-05	0.000391	CcSEcCtD
Sildenafil—Pharyngitis—Epirubicin—pancreatic cancer	7.92e-05	0.00039	CcSEcCtD
Sildenafil—Sweating—Doxorubicin—pancreatic cancer	7.89e-05	0.000388	CcSEcCtD
Sildenafil—Urinary tract disorder—Epirubicin—pancreatic cancer	7.88e-05	0.000388	CcSEcCtD
Sildenafil—Oedema peripheral—Epirubicin—pancreatic cancer	7.86e-05	0.000387	CcSEcCtD
Sildenafil—Hypotension—Docetaxel—pancreatic cancer	7.86e-05	0.000387	CcSEcCtD
Sildenafil—Haematuria—Doxorubicin—pancreatic cancer	7.84e-05	0.000386	CcSEcCtD
Sildenafil—Connective tissue disorder—Epirubicin—pancreatic cancer	7.84e-05	0.000386	CcSEcCtD
Sildenafil—Urethral disorder—Epirubicin—pancreatic cancer	7.82e-05	0.000385	CcSEcCtD
Sildenafil—Epistaxis—Doxorubicin—pancreatic cancer	7.76e-05	0.000382	CcSEcCtD
Sildenafil—Vomiting—Irinotecan—pancreatic cancer	7.73e-05	0.000381	CcSEcCtD
Sildenafil—Sinusitis—Doxorubicin—pancreatic cancer	7.72e-05	0.00038	CcSEcCtD
Sildenafil—Dizziness—Fluorouracil—pancreatic cancer	7.7e-05	0.000379	CcSEcCtD
Sildenafil—Visual impairment—Epirubicin—pancreatic cancer	7.69e-05	0.000379	CcSEcCtD
Sildenafil—Rash—Irinotecan—pancreatic cancer	7.67e-05	0.000378	CcSEcCtD
Sildenafil—Dermatitis—Irinotecan—pancreatic cancer	7.66e-05	0.000377	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	7.66e-05	0.000377	CcSEcCtD
Sildenafil—Headache—Irinotecan—pancreatic cancer	7.62e-05	0.000375	CcSEcCtD
Sildenafil—Insomnia—Docetaxel—pancreatic cancer	7.6e-05	0.000374	CcSEcCtD
Sildenafil—Paraesthesia—Docetaxel—pancreatic cancer	7.55e-05	0.000372	CcSEcCtD
Sildenafil—Erythema multiforme—Epirubicin—pancreatic cancer	7.55e-05	0.000372	CcSEcCtD
Sildenafil—Vomiting—Gemcitabine—pancreatic cancer	7.53e-05	0.000371	CcSEcCtD
Sildenafil—Dyspnoea—Docetaxel—pancreatic cancer	7.5e-05	0.000369	CcSEcCtD
Sildenafil—Somnolence—Docetaxel—pancreatic cancer	7.47e-05	0.000368	CcSEcCtD
Sildenafil—Rash—Gemcitabine—pancreatic cancer	7.47e-05	0.000368	CcSEcCtD
Sildenafil—Dermatitis—Gemcitabine—pancreatic cancer	7.46e-05	0.000367	CcSEcCtD
Sildenafil—Eye disorder—Epirubicin—pancreatic cancer	7.46e-05	0.000367	CcSEcCtD
Sildenafil—Tinnitus—Epirubicin—pancreatic cancer	7.44e-05	0.000366	CcSEcCtD
Sildenafil—Haemoglobin—Doxorubicin—pancreatic cancer	7.42e-05	0.000366	CcSEcCtD
Sildenafil—Headache—Gemcitabine—pancreatic cancer	7.42e-05	0.000365	CcSEcCtD
Sildenafil—Flushing—Epirubicin—pancreatic cancer	7.41e-05	0.000365	CcSEcCtD
Sildenafil—Cardiac disorder—Epirubicin—pancreatic cancer	7.41e-05	0.000365	CcSEcCtD
Sildenafil—Vomiting—Fluorouracil—pancreatic cancer	7.41e-05	0.000365	CcSEcCtD
Sildenafil—Rhinitis—Doxorubicin—pancreatic cancer	7.4e-05	0.000365	CcSEcCtD
Sildenafil—Dyspepsia—Docetaxel—pancreatic cancer	7.4e-05	0.000364	CcSEcCtD
Sildenafil—Haemorrhage—Doxorubicin—pancreatic cancer	7.39e-05	0.000364	CcSEcCtD
Sildenafil—Hypoaesthesia—Doxorubicin—pancreatic cancer	7.35e-05	0.000362	CcSEcCtD
Sildenafil—Rash—Fluorouracil—pancreatic cancer	7.34e-05	0.000362	CcSEcCtD
Sildenafil—Dermatitis—Fluorouracil—pancreatic cancer	7.34e-05	0.000361	CcSEcCtD
Sildenafil—Pharyngitis—Doxorubicin—pancreatic cancer	7.33e-05	0.000361	CcSEcCtD
Sildenafil—Decreased appetite—Docetaxel—pancreatic cancer	7.31e-05	0.00036	CcSEcCtD
Sildenafil—Headache—Fluorouracil—pancreatic cancer	7.3e-05	0.000359	CcSEcCtD
Sildenafil—Urinary tract disorder—Doxorubicin—pancreatic cancer	7.29e-05	0.000359	CcSEcCtD
Sildenafil—Oedema peripheral—Doxorubicin—pancreatic cancer	7.28e-05	0.000358	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Docetaxel—pancreatic cancer	7.26e-05	0.000357	CcSEcCtD
Sildenafil—Connective tissue disorder—Doxorubicin—pancreatic cancer	7.26e-05	0.000357	CcSEcCtD
Sildenafil—Fatigue—Docetaxel—pancreatic cancer	7.25e-05	0.000357	CcSEcCtD
Sildenafil—Angiopathy—Epirubicin—pancreatic cancer	7.24e-05	0.000357	CcSEcCtD
Sildenafil—Urethral disorder—Doxorubicin—pancreatic cancer	7.24e-05	0.000356	CcSEcCtD
Sildenafil—Nausea—Irinotecan—pancreatic cancer	7.22e-05	0.000356	CcSEcCtD
Sildenafil—Immune system disorder—Epirubicin—pancreatic cancer	7.21e-05	0.000355	CcSEcCtD
Sildenafil—Mediastinal disorder—Epirubicin—pancreatic cancer	7.19e-05	0.000354	CcSEcCtD
Sildenafil—Constipation—Docetaxel—pancreatic cancer	7.19e-05	0.000354	CcSEcCtD
Sildenafil—Pain—Docetaxel—pancreatic cancer	7.19e-05	0.000354	CcSEcCtD
Sildenafil—Chills—Epirubicin—pancreatic cancer	7.16e-05	0.000353	CcSEcCtD
Sildenafil—Arrhythmia—Epirubicin—pancreatic cancer	7.13e-05	0.000351	CcSEcCtD
Sildenafil—Visual impairment—Doxorubicin—pancreatic cancer	7.12e-05	0.00035	CcSEcCtD
Sildenafil—Alopecia—Epirubicin—pancreatic cancer	7.05e-05	0.000347	CcSEcCtD
Sildenafil—Nausea—Gemcitabine—pancreatic cancer	7.04e-05	0.000347	CcSEcCtD
Sildenafil—Mental disorder—Epirubicin—pancreatic cancer	6.99e-05	0.000344	CcSEcCtD
Sildenafil—Erythema multiforme—Doxorubicin—pancreatic cancer	6.98e-05	0.000344	CcSEcCtD
Sildenafil—Erythema—Epirubicin—pancreatic cancer	6.95e-05	0.000342	CcSEcCtD
Sildenafil—Malnutrition—Epirubicin—pancreatic cancer	6.95e-05	0.000342	CcSEcCtD
Sildenafil—Feeling abnormal—Docetaxel—pancreatic cancer	6.93e-05	0.000341	CcSEcCtD
Sildenafil—Nausea—Fluorouracil—pancreatic cancer	6.92e-05	0.000341	CcSEcCtD
Sildenafil—Eye disorder—Doxorubicin—pancreatic cancer	6.9e-05	0.00034	CcSEcCtD
Sildenafil—Tinnitus—Doxorubicin—pancreatic cancer	6.89e-05	0.000339	CcSEcCtD
Sildenafil—Gastrointestinal pain—Docetaxel—pancreatic cancer	6.87e-05	0.000339	CcSEcCtD
Sildenafil—Flushing—Doxorubicin—pancreatic cancer	6.85e-05	0.000338	CcSEcCtD
Sildenafil—Cardiac disorder—Doxorubicin—pancreatic cancer	6.85e-05	0.000338	CcSEcCtD
Sildenafil—Flatulence—Epirubicin—pancreatic cancer	6.85e-05	0.000337	CcSEcCtD
Sildenafil—Tension—Epirubicin—pancreatic cancer	6.82e-05	0.000336	CcSEcCtD
Sildenafil—Nervousness—Epirubicin—pancreatic cancer	6.75e-05	0.000332	CcSEcCtD
Sildenafil—Back pain—Epirubicin—pancreatic cancer	6.72e-05	0.000331	CcSEcCtD
Sildenafil—Angiopathy—Doxorubicin—pancreatic cancer	6.7e-05	0.00033	CcSEcCtD
Sildenafil—Immune system disorder—Doxorubicin—pancreatic cancer	6.67e-05	0.000328	CcSEcCtD
Sildenafil—Mediastinal disorder—Doxorubicin—pancreatic cancer	6.66e-05	0.000328	CcSEcCtD
Sildenafil—Abdominal pain—Docetaxel—pancreatic cancer	6.65e-05	0.000327	CcSEcCtD
Sildenafil—Body temperature increased—Docetaxel—pancreatic cancer	6.65e-05	0.000327	CcSEcCtD
Sildenafil—Chills—Doxorubicin—pancreatic cancer	6.63e-05	0.000326	CcSEcCtD
Sildenafil—Arrhythmia—Doxorubicin—pancreatic cancer	6.6e-05	0.000325	CcSEcCtD
Sildenafil—Vision blurred—Epirubicin—pancreatic cancer	6.55e-05	0.000322	CcSEcCtD
Sildenafil—Alopecia—Doxorubicin—pancreatic cancer	6.53e-05	0.000321	CcSEcCtD
Sildenafil—Mental disorder—Doxorubicin—pancreatic cancer	6.47e-05	0.000319	CcSEcCtD
Sildenafil—Ill-defined disorder—Epirubicin—pancreatic cancer	6.45e-05	0.000317	CcSEcCtD
Sildenafil—Erythema—Doxorubicin—pancreatic cancer	6.43e-05	0.000317	CcSEcCtD
Sildenafil—Malnutrition—Doxorubicin—pancreatic cancer	6.43e-05	0.000317	CcSEcCtD
Sildenafil—Anaemia—Epirubicin—pancreatic cancer	6.42e-05	0.000316	CcSEcCtD
Sildenafil—Agitation—Epirubicin—pancreatic cancer	6.38e-05	0.000314	CcSEcCtD
Sildenafil—Flatulence—Doxorubicin—pancreatic cancer	6.33e-05	0.000312	CcSEcCtD
Sildenafil—Tension—Doxorubicin—pancreatic cancer	6.31e-05	0.000311	CcSEcCtD
Sildenafil—Malaise—Epirubicin—pancreatic cancer	6.27e-05	0.000309	CcSEcCtD
Sildenafil—Nervousness—Doxorubicin—pancreatic cancer	6.24e-05	0.000307	CcSEcCtD
Sildenafil—Vertigo—Epirubicin—pancreatic cancer	6.24e-05	0.000307	CcSEcCtD
Sildenafil—Syncope—Epirubicin—pancreatic cancer	6.23e-05	0.000307	CcSEcCtD
Sildenafil—Leukopenia—Epirubicin—pancreatic cancer	6.22e-05	0.000306	CcSEcCtD
Sildenafil—Back pain—Doxorubicin—pancreatic cancer	6.22e-05	0.000306	CcSEcCtD
Sildenafil—Hypersensitivity—Docetaxel—pancreatic cancer	6.19e-05	0.000305	CcSEcCtD
Sildenafil—Palpitations—Epirubicin—pancreatic cancer	6.14e-05	0.000302	CcSEcCtD
Sildenafil—Loss of consciousness—Epirubicin—pancreatic cancer	6.11e-05	0.000301	CcSEcCtD
Sildenafil—Cough—Epirubicin—pancreatic cancer	6.06e-05	0.000299	CcSEcCtD
Sildenafil—Vision blurred—Doxorubicin—pancreatic cancer	6.06e-05	0.000298	CcSEcCtD
Sildenafil—Asthenia—Docetaxel—pancreatic cancer	6.03e-05	0.000297	CcSEcCtD
Sildenafil—Convulsion—Epirubicin—pancreatic cancer	6.02e-05	0.000296	CcSEcCtD
Sildenafil—Hypertension—Epirubicin—pancreatic cancer	6e-05	0.000295	CcSEcCtD
Sildenafil—Ill-defined disorder—Doxorubicin—pancreatic cancer	5.96e-05	0.000294	CcSEcCtD
Sildenafil—Pruritus—Docetaxel—pancreatic cancer	5.95e-05	0.000293	CcSEcCtD
Sildenafil—Anaemia—Doxorubicin—pancreatic cancer	5.94e-05	0.000293	CcSEcCtD
Sildenafil—Chest pain—Epirubicin—pancreatic cancer	5.92e-05	0.000291	CcSEcCtD
Sildenafil—Arthralgia—Epirubicin—pancreatic cancer	5.92e-05	0.000291	CcSEcCtD
Sildenafil—Myalgia—Epirubicin—pancreatic cancer	5.92e-05	0.000291	CcSEcCtD
Sildenafil—Agitation—Doxorubicin—pancreatic cancer	5.91e-05	0.000291	CcSEcCtD
Sildenafil—Anxiety—Epirubicin—pancreatic cancer	5.89e-05	0.00029	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	5.87e-05	0.000289	CcSEcCtD
Sildenafil—Discomfort—Epirubicin—pancreatic cancer	5.84e-05	0.000288	CcSEcCtD
Sildenafil—Malaise—Doxorubicin—pancreatic cancer	5.8e-05	0.000285	CcSEcCtD
Sildenafil—Dry mouth—Epirubicin—pancreatic cancer	5.79e-05	0.000285	CcSEcCtD
Sildenafil—Vertigo—Doxorubicin—pancreatic cancer	5.78e-05	0.000284	CcSEcCtD
Sildenafil—Syncope—Doxorubicin—pancreatic cancer	5.77e-05	0.000284	CcSEcCtD
Sildenafil—Leukopenia—Doxorubicin—pancreatic cancer	5.75e-05	0.000283	CcSEcCtD
Sildenafil—Diarrhoea—Docetaxel—pancreatic cancer	5.75e-05	0.000283	CcSEcCtD
Sildenafil—Palpitations—Doxorubicin—pancreatic cancer	5.68e-05	0.00028	CcSEcCtD
Sildenafil—Oedema—Epirubicin—pancreatic cancer	5.67e-05	0.000279	CcSEcCtD
Sildenafil—Loss of consciousness—Doxorubicin—pancreatic cancer	5.65e-05	0.000278	CcSEcCtD
Sildenafil—Infection—Epirubicin—pancreatic cancer	5.63e-05	0.000277	CcSEcCtD
Sildenafil—Cough—Doxorubicin—pancreatic cancer	5.61e-05	0.000276	CcSEcCtD
Sildenafil—Shock—Epirubicin—pancreatic cancer	5.58e-05	0.000275	CcSEcCtD
Sildenafil—Convulsion—Doxorubicin—pancreatic cancer	5.57e-05	0.000274	CcSEcCtD
Sildenafil—Nervous system disorder—Epirubicin—pancreatic cancer	5.56e-05	0.000274	CcSEcCtD
Sildenafil—Dizziness—Docetaxel—pancreatic cancer	5.56e-05	0.000274	CcSEcCtD
Sildenafil—Hypertension—Doxorubicin—pancreatic cancer	5.55e-05	0.000273	CcSEcCtD
Sildenafil—Tachycardia—Epirubicin—pancreatic cancer	5.53e-05	0.000273	CcSEcCtD
Sildenafil—Skin disorder—Epirubicin—pancreatic cancer	5.51e-05	0.000271	CcSEcCtD
Sildenafil—Hyperhidrosis—Epirubicin—pancreatic cancer	5.48e-05	0.00027	CcSEcCtD
Sildenafil—Myalgia—Doxorubicin—pancreatic cancer	5.47e-05	0.00027	CcSEcCtD
Sildenafil—Arthralgia—Doxorubicin—pancreatic cancer	5.47e-05	0.00027	CcSEcCtD
Sildenafil—Chest pain—Doxorubicin—pancreatic cancer	5.47e-05	0.00027	CcSEcCtD
Sildenafil—Anxiety—Doxorubicin—pancreatic cancer	5.45e-05	0.000269	CcSEcCtD
Sildenafil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	5.44e-05	0.000268	CcSEcCtD
Sildenafil—Discomfort—Doxorubicin—pancreatic cancer	5.41e-05	0.000266	CcSEcCtD
Sildenafil—Anorexia—Epirubicin—pancreatic cancer	5.41e-05	0.000266	CcSEcCtD
Sildenafil—Dry mouth—Doxorubicin—pancreatic cancer	5.35e-05	0.000264	CcSEcCtD
Sildenafil—Vomiting—Docetaxel—pancreatic cancer	5.35e-05	0.000263	CcSEcCtD
Sildenafil—Rash—Docetaxel—pancreatic cancer	5.3e-05	0.000261	CcSEcCtD
Sildenafil—Hypotension—Epirubicin—pancreatic cancer	5.3e-05	0.000261	CcSEcCtD
Sildenafil—Dermatitis—Docetaxel—pancreatic cancer	5.3e-05	0.000261	CcSEcCtD
Sildenafil—Headache—Docetaxel—pancreatic cancer	5.27e-05	0.000259	CcSEcCtD
Sildenafil—Oedema—Doxorubicin—pancreatic cancer	5.25e-05	0.000258	CcSEcCtD
Sildenafil—Infection—Doxorubicin—pancreatic cancer	5.21e-05	0.000257	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	5.17e-05	0.000254	CcSEcCtD
Sildenafil—Shock—Doxorubicin—pancreatic cancer	5.16e-05	0.000254	CcSEcCtD
Sildenafil—Nervous system disorder—Doxorubicin—pancreatic cancer	5.15e-05	0.000253	CcSEcCtD
Sildenafil—Insomnia—Epirubicin—pancreatic cancer	5.13e-05	0.000253	CcSEcCtD
Sildenafil—Tachycardia—Doxorubicin—pancreatic cancer	5.12e-05	0.000252	CcSEcCtD
Sildenafil—Skin disorder—Doxorubicin—pancreatic cancer	5.1e-05	0.000251	CcSEcCtD
Sildenafil—Paraesthesia—Epirubicin—pancreatic cancer	5.09e-05	0.000251	CcSEcCtD
Sildenafil—Hyperhidrosis—Doxorubicin—pancreatic cancer	5.07e-05	0.00025	CcSEcCtD
Sildenafil—Dyspnoea—Epirubicin—pancreatic cancer	5.06e-05	0.000249	CcSEcCtD
Sildenafil—Somnolence—Epirubicin—pancreatic cancer	5.04e-05	0.000248	CcSEcCtD
Sildenafil—Anorexia—Doxorubicin—pancreatic cancer	5e-05	0.000246	CcSEcCtD
Sildenafil—Nausea—Docetaxel—pancreatic cancer	4.99e-05	0.000246	CcSEcCtD
Sildenafil—Dyspepsia—Epirubicin—pancreatic cancer	4.99e-05	0.000246	CcSEcCtD
Sildenafil—Decreased appetite—Epirubicin—pancreatic cancer	4.93e-05	0.000243	CcSEcCtD
Sildenafil—Hypotension—Doxorubicin—pancreatic cancer	4.9e-05	0.000241	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Epirubicin—pancreatic cancer	4.9e-05	0.000241	CcSEcCtD
Sildenafil—Fatigue—Epirubicin—pancreatic cancer	4.89e-05	0.000241	CcSEcCtD
Sildenafil—Constipation—Epirubicin—pancreatic cancer	4.85e-05	0.000239	CcSEcCtD
Sildenafil—Pain—Epirubicin—pancreatic cancer	4.85e-05	0.000239	CcSEcCtD
Sildenafil—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	4.78e-05	0.000235	CcSEcCtD
Sildenafil—Insomnia—Doxorubicin—pancreatic cancer	4.75e-05	0.000234	CcSEcCtD
Sildenafil—Paraesthesia—Doxorubicin—pancreatic cancer	4.71e-05	0.000232	CcSEcCtD
Sildenafil—Dyspnoea—Doxorubicin—pancreatic cancer	4.68e-05	0.00023	CcSEcCtD
Sildenafil—Feeling abnormal—Epirubicin—pancreatic cancer	4.67e-05	0.00023	CcSEcCtD
Sildenafil—Somnolence—Doxorubicin—pancreatic cancer	4.66e-05	0.00023	CcSEcCtD
Sildenafil—Gastrointestinal pain—Epirubicin—pancreatic cancer	4.64e-05	0.000228	CcSEcCtD
Sildenafil—Dyspepsia—Doxorubicin—pancreatic cancer	4.62e-05	0.000227	CcSEcCtD
Sildenafil—Decreased appetite—Doxorubicin—pancreatic cancer	4.56e-05	0.000225	CcSEcCtD
Sildenafil—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	4.53e-05	0.000223	CcSEcCtD
Sildenafil—Fatigue—Doxorubicin—pancreatic cancer	4.52e-05	0.000223	CcSEcCtD
Sildenafil—Urticaria—Epirubicin—pancreatic cancer	4.5e-05	0.000222	CcSEcCtD
Sildenafil—Pain—Doxorubicin—pancreatic cancer	4.49e-05	0.000221	CcSEcCtD
Sildenafil—Constipation—Doxorubicin—pancreatic cancer	4.49e-05	0.000221	CcSEcCtD
Sildenafil—Body temperature increased—Epirubicin—pancreatic cancer	4.48e-05	0.000221	CcSEcCtD
Sildenafil—Abdominal pain—Epirubicin—pancreatic cancer	4.48e-05	0.000221	CcSEcCtD
Sildenafil—Feeling abnormal—Doxorubicin—pancreatic cancer	4.32e-05	0.000213	CcSEcCtD
Sildenafil—Gastrointestinal pain—Doxorubicin—pancreatic cancer	4.29e-05	0.000211	CcSEcCtD
Sildenafil—Hypersensitivity—Epirubicin—pancreatic cancer	4.18e-05	0.000206	CcSEcCtD
Sildenafil—Urticaria—Doxorubicin—pancreatic cancer	4.17e-05	0.000205	CcSEcCtD
Sildenafil—Body temperature increased—Doxorubicin—pancreatic cancer	4.15e-05	0.000204	CcSEcCtD
Sildenafil—Abdominal pain—Doxorubicin—pancreatic cancer	4.15e-05	0.000204	CcSEcCtD
Sildenafil—Asthenia—Epirubicin—pancreatic cancer	4.07e-05	0.0002	CcSEcCtD
Sildenafil—Pruritus—Epirubicin—pancreatic cancer	4.01e-05	0.000198	CcSEcCtD
Sildenafil—Diarrhoea—Epirubicin—pancreatic cancer	3.88e-05	0.000191	CcSEcCtD
Sildenafil—Hypersensitivity—Doxorubicin—pancreatic cancer	3.87e-05	0.00019	CcSEcCtD
Sildenafil—Asthenia—Doxorubicin—pancreatic cancer	3.76e-05	0.000185	CcSEcCtD
Sildenafil—Dizziness—Epirubicin—pancreatic cancer	3.75e-05	0.000185	CcSEcCtD
Sildenafil—Pruritus—Doxorubicin—pancreatic cancer	3.71e-05	0.000183	CcSEcCtD
Sildenafil—Vomiting—Epirubicin—pancreatic cancer	3.61e-05	0.000178	CcSEcCtD
Sildenafil—Diarrhoea—Doxorubicin—pancreatic cancer	3.59e-05	0.000177	CcSEcCtD
Sildenafil—Rash—Epirubicin—pancreatic cancer	3.58e-05	0.000176	CcSEcCtD
Sildenafil—Dermatitis—Epirubicin—pancreatic cancer	3.57e-05	0.000176	CcSEcCtD
Sildenafil—Headache—Epirubicin—pancreatic cancer	3.55e-05	0.000175	CcSEcCtD
Sildenafil—Dizziness—Doxorubicin—pancreatic cancer	3.47e-05	0.000171	CcSEcCtD
Sildenafil—Nausea—Epirubicin—pancreatic cancer	3.37e-05	0.000166	CcSEcCtD
Sildenafil—Vomiting—Doxorubicin—pancreatic cancer	3.34e-05	0.000164	CcSEcCtD
Sildenafil—Rash—Doxorubicin—pancreatic cancer	3.31e-05	0.000163	CcSEcCtD
Sildenafil—Dermatitis—Doxorubicin—pancreatic cancer	3.31e-05	0.000163	CcSEcCtD
Sildenafil—Headache—Doxorubicin—pancreatic cancer	3.29e-05	0.000162	CcSEcCtD
Sildenafil—Nausea—Doxorubicin—pancreatic cancer	3.12e-05	0.000153	CcSEcCtD
Sildenafil—PDE6G—Signaling Pathways—MMP9—pancreatic cancer	1.39e-05	0.000358	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PRSS1—pancreatic cancer	1.39e-05	0.000358	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—PTEN—pancreatic cancer	1.38e-05	0.000356	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—VEGFA—pancreatic cancer	1.38e-05	0.000355	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PRSS1—pancreatic cancer	1.37e-05	0.000355	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—NRAS—pancreatic cancer	1.36e-05	0.000351	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PIK3CG—pancreatic cancer	1.35e-05	0.000347	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—PIK3CD—pancreatic cancer	1.32e-05	0.000342	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—ARG2—pancreatic cancer	1.31e-05	0.000337	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PPARG—pancreatic cancer	1.3e-05	0.000335	CbGpPWpGaD
Sildenafil—PDE6G—Disease—HRAS—pancreatic cancer	1.29e-05	0.000332	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—SRC—pancreatic cancer	1.28e-05	0.00033	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—PIK3CB—pancreatic cancer	1.27e-05	0.000328	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—TGFB1—pancreatic cancer	1.26e-05	0.000326	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—VEGFA—pancreatic cancer	1.25e-05	0.000322	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—SMAD4—pancreatic cancer	1.23e-05	0.000319	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—STAT3—pancreatic cancer	1.23e-05	0.000319	CbGpPWpGaD
Sildenafil—ABCC5—Disease—PIK3CB—pancreatic cancer	1.23e-05	0.000318	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—NRAS—pancreatic cancer	1.23e-05	0.000318	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—CXCL8—pancreatic cancer	1.22e-05	0.000315	CbGpPWpGaD
Sildenafil—ABCC5—Disease—PTGS2—pancreatic cancer	1.22e-05	0.000315	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—HES1—pancreatic cancer	1.2e-05	0.000311	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—ARG2—pancreatic cancer	1.2e-05	0.00031	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GLP1R—pancreatic cancer	1.19e-05	0.000308	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—ARG2—pancreatic cancer	1.19e-05	0.000308	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—CD44—pancreatic cancer	1.19e-05	0.000308	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GLP1R—pancreatic cancer	1.19e-05	0.000307	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PIK3CD—pancreatic cancer	1.18e-05	0.000305	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—DPYD—pancreatic cancer	1.17e-05	0.000303	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—DPYD—pancreatic cancer	1.17e-05	0.000303	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—KRAS—pancreatic cancer	1.17e-05	0.000302	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—PIK3CB—pancreatic cancer	1.15e-05	0.000298	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.15e-05	0.000297	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—MYC—pancreatic cancer	1.15e-05	0.000296	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—TGFB1—pancreatic cancer	1.14e-05	0.000295	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—TYMP—pancreatic cancer	1.14e-05	0.000295	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—GCG—pancreatic cancer	1.14e-05	0.000295	CbGpPWpGaD
Sildenafil—PDE6G—Disease—AKT1—pancreatic cancer	1.14e-05	0.000293	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GLP1R—pancreatic cancer	1.13e-05	0.000291	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—EGFR—pancreatic cancer	1.12e-05	0.00029	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—SLC2A2—pancreatic cancer	1.11e-05	0.000288	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—SLC2A2—pancreatic cancer	1.11e-05	0.000287	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—CXCL8—pancreatic cancer	1.11e-05	0.000286	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—DPYD—pancreatic cancer	1.11e-05	0.000286	CbGpPWpGaD
Sildenafil—ABCC5—Disease—CTNNB1—pancreatic cancer	1.09e-05	0.000282	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—PIK3CA—pancreatic cancer	1.07e-05	0.000277	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—STK11—pancreatic cancer	1.07e-05	0.000277	CbGpPWpGaD
Sildenafil—ABCC5—Disease—PTEN—pancreatic cancer	1.06e-05	0.000275	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—KRAS—pancreatic cancer	1.06e-05	0.000273	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TERT—pancreatic cancer	1.06e-05	0.000273	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—TYMP—pancreatic cancer	1.05e-05	0.000271	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—SLC2A2—pancreatic cancer	1.05e-05	0.000271	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—TYMP—pancreatic cancer	1.04e-05	0.000269	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.04e-05	0.000268	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—TP53—pancreatic cancer	1.04e-05	0.000268	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PIK3CB—pancreatic cancer	1.03e-05	0.000266	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PTGS2—pancreatic cancer	1.02e-05	0.000264	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—HIF1A—pancreatic cancer	1.01e-05	0.000261	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TSC2—pancreatic cancer	1.01e-05	0.00026	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1e-05	0.000259	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—HRAS—pancreatic cancer	9.94e-06	0.000257	CbGpPWpGaD
Sildenafil—ABCC5—Disease—SRC—pancreatic cancer	9.87e-06	0.000255	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—APOE—pancreatic cancer	9.86e-06	0.000254	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—PIK3CA—pancreatic cancer	9.73e-06	0.000251	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—KDR—pancreatic cancer	9.66e-06	0.000249	CbGpPWpGaD
Sildenafil—ABCC5—Disease—STAT3—pancreatic cancer	9.52e-06	0.000246	CbGpPWpGaD
Sildenafil—ABCC5—Disease—NRAS—pancreatic cancer	9.49e-06	0.000245	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	9.43e-06	0.000243	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—TP53—pancreatic cancer	9.42e-06	0.000243	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—TYMS—pancreatic cancer	9.24e-06	0.000238	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GLP1R—pancreatic cancer	9.21e-06	0.000238	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—NFKBIA—pancreatic cancer	9.18e-06	0.000237	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	9.14e-06	0.000236	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—NOTCH1—pancreatic cancer	9.1e-06	0.000235	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PRSS1—pancreatic cancer	9.07e-06	0.000234	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—DPYD—pancreatic cancer	9.06e-06	0.000234	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—HRAS—pancreatic cancer	9.01e-06	0.000232	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PTEN—pancreatic cancer	8.91e-06	0.00023	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PIK3CG—pancreatic cancer	8.89e-06	0.00023	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—NRAS—pancreatic cancer	8.89e-06	0.00023	CbGpPWpGaD
Sildenafil—ABCC5—Disease—MYC—pancreatic cancer	8.84e-06	0.000228	CbGpPWpGaD
Sildenafil—ABCC5—Disease—TGFB1—pancreatic cancer	8.82e-06	0.000228	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—EGF—pancreatic cancer	8.79e-06	0.000227	CbGpPWpGaD
Sildenafil—ABCC4—Hemostasis—AKT1—pancreatic cancer	8.78e-06	0.000227	CbGpPWpGaD
Sildenafil—ABCC5—Disease—EGFR—pancreatic cancer	8.65e-06	0.000223	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—CD44—pancreatic cancer	8.63e-06	0.000223	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—CD44—pancreatic cancer	8.61e-06	0.000222	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	8.6e-06	0.000222	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	8.6e-06	0.000222	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	8.51e-06	0.00022	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GLP1R—pancreatic cancer	8.47e-06	0.000219	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GLP1R—pancreatic cancer	8.4e-06	0.000217	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—DPYD—pancreatic cancer	8.33e-06	0.000215	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—GCG—pancreatic cancer	8.27e-06	0.000214	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—DPYD—pancreatic cancer	8.26e-06	0.000213	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—GCG—pancreatic cancer	8.26e-06	0.000213	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	8.21e-06	0.000212	CbGpPWpGaD
Sildenafil—ABCC5—Disease—KRAS—pancreatic cancer	8.17e-06	0.000211	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—CD44—pancreatic cancer	8.14e-06	0.00021	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—EGFR—pancreatic cancer	8.1e-06	0.000209	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	7.97e-06	0.000206	CbGpPWpGaD
Sildenafil—PDE6G—Signaling Pathways—AKT1—pancreatic cancer	7.95e-06	0.000205	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—SLC2A2—pancreatic cancer	7.91e-06	0.000204	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	7.89e-06	0.000204	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—ARG2—pancreatic cancer	7.86e-06	0.000203	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—SLC2A2—pancreatic cancer	7.84e-06	0.000202	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PIK3CD—pancreatic cancer	7.82e-06	0.000202	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—GCG—pancreatic cancer	7.8e-06	0.000201	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—STK11—pancreatic cancer	7.78e-06	0.000201	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—STK11—pancreatic cancer	7.76e-06	0.0002	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	7.76e-06	0.0002	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—PIK3CA—pancreatic cancer	7.75e-06	0.0002	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—KRAS—pancreatic cancer	7.66e-06	0.000198	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—APOE—pancreatic cancer	7.51e-06	0.000194	CbGpPWpGaD
Sildenafil—ABCC5—Disease—PIK3CA—pancreatic cancer	7.51e-06	0.000194	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	7.49e-06	0.000193	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	7.48e-06	0.000193	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—STK11—pancreatic cancer	7.33e-06	0.000189	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—PIK3CA—pancreatic cancer	7.03e-06	0.000182	CbGpPWpGaD
Sildenafil—ABCC5—Disease—HRAS—pancreatic cancer	6.94e-06	0.000179	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	6.88e-06	0.000178	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—TYMP—pancreatic cancer	6.87e-06	0.000177	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	6.82e-06	0.000176	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PIK3CB—pancreatic cancer	6.82e-06	0.000176	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PIK3CG—pancreatic cancer	6.78e-06	0.000175	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—TYMS—pancreatic cancer	6.69e-06	0.000173	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—TYMS—pancreatic cancer	6.68e-06	0.000172	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—CD44—pancreatic cancer	6.66e-06	0.000172	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CXCL8—pancreatic cancer	6.55e-06	0.000169	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PPARG—pancreatic cancer	6.54e-06	0.000169	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	6.52e-06	0.000168	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—HRAS—pancreatic cancer	6.51e-06	0.000168	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	6.46e-06	0.000167	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—GCG—pancreatic cancer	6.38e-06	0.000165	CbGpPWpGaD
Sildenafil—ADORA2A—GPCR downstream signaling—AKT1—pancreatic cancer	6.33e-06	0.000163	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—TYMS—pancreatic cancer	6.31e-06	0.000163	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—PIK3CA—pancreatic cancer	6.29e-06	0.000162	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CASP3—pancreatic cancer	6.27e-06	0.000162	CbGpPWpGaD
Sildenafil—ABCC5—Disease—AKT1—pancreatic cancer	6.13e-06	0.000158	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—CD44—pancreatic cancer	6.12e-06	0.000158	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CCND1—pancreatic cancer	6.1e-06	0.000158	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—CD44—pancreatic cancer	6.07e-06	0.000157	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—CTNNB1—pancreatic cancer	6.04e-06	0.000156	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—STK11—pancreatic cancer	6e-06	0.000155	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PIK3CD—pancreatic cancer	5.96e-06	0.000154	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	5.94e-06	0.000153	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MMP9—pancreatic cancer	5.92e-06	0.000153	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	5.89e-06	0.000152	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PTEN—pancreatic cancer	5.89e-06	0.000152	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—GCG—pancreatic cancer	5.87e-06	0.000152	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—GCG—pancreatic cancer	5.82e-06	0.00015	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling by GPCR—AKT1—pancreatic cancer	5.75e-06	0.000148	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.63e-06	0.000145	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GLP1R—pancreatic cancer	5.54e-06	0.000143	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—STK11—pancreatic cancer	5.52e-06	0.000142	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—STK11—pancreatic cancer	5.47e-06	0.000141	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—SRC—pancreatic cancer	5.46e-06	0.000141	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—DPYD—pancreatic cancer	5.45e-06	0.000141	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—APOE—pancreatic cancer	5.44e-06	0.00014	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—APOE—pancreatic cancer	5.43e-06	0.00014	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—VEGFA—pancreatic cancer	5.32e-06	0.000137	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—STAT3—pancreatic cancer	5.27e-06	0.000136	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—NRAS—pancreatic cancer	5.25e-06	0.000136	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PIK3CB—pancreatic cancer	5.2e-06	0.000134	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	5.17e-06	0.000133	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—TYMS—pancreatic cancer	5.16e-06	0.000133	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PTGS2—pancreatic cancer	5.15e-06	0.000133	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	5.14e-06	0.000133	CbGpPWpGaD
Sildenafil—ABCC5—Metabolism—AKT1—pancreatic cancer	5.14e-06	0.000133	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—APOE—pancreatic cancer	5.13e-06	0.000132	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PIK3CG—pancreatic cancer	4.91e-06	0.000127	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PIK3CG—pancreatic cancer	4.9e-06	0.000127	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—MYC—pancreatic cancer	4.89e-06	0.000126	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TGFB1—pancreatic cancer	4.88e-06	0.000126	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	4.86e-06	0.000125	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—EGFR—pancreatic cancer	4.79e-06	0.000124	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—TYMS—pancreatic cancer	4.75e-06	0.000123	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PPARG—pancreatic cancer	4.74e-06	0.000122	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PPARG—pancreatic cancer	4.73e-06	0.000122	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—TYMS—pancreatic cancer	4.71e-06	0.000122	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PIK3CG—pancreatic cancer	4.63e-06	0.00012	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—KRAS—pancreatic cancer	4.52e-06	0.000117	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PTEN—pancreatic cancer	4.49e-06	0.000116	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PPARG—pancreatic cancer	4.47e-06	0.000115	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PIK3CD—pancreatic cancer	4.32e-06	0.000111	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PIK3CD—pancreatic cancer	4.31e-06	0.000111	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—APOE—pancreatic cancer	4.2e-06	0.000108	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—PIK3CA—pancreatic cancer	4.15e-06	0.000107	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PIK3CD—pancreatic cancer	4.07e-06	0.000105	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—TP53—pancreatic cancer	4.02e-06	0.000104	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—CD44—pancreatic cancer	4e-06	0.000103	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.97e-06	0.000103	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—APOE—pancreatic cancer	3.86e-06	9.97e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—HRAS—pancreatic cancer	3.84e-06	9.92e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—GCG—pancreatic cancer	3.84e-06	9.91e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—APOE—pancreatic cancer	3.83e-06	9.88e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	3.79e-06	9.78e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PIK3CB—pancreatic cancer	3.76e-06	9.71e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PIK3CB—pancreatic cancer	3.76e-06	9.69e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PTGS2—pancreatic cancer	3.73e-06	9.63e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PTGS2—pancreatic cancer	3.72e-06	9.61e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PPARG—pancreatic cancer	3.66e-06	9.44e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.62e-06	9.35e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—STK11—pancreatic cancer	3.61e-06	9.32e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PIK3CB—pancreatic cancer	3.55e-06	9.16e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PTGS2—pancreatic cancer	3.52e-06	9.08e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	3.49e-06	9e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	3.45e-06	8.92e-05	CbGpPWpGaD
Sildenafil—ADORA2A—Signaling Pathways—AKT1—pancreatic cancer	3.39e-06	8.76e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PPARG—pancreatic cancer	3.36e-06	8.68e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PPARG—pancreatic cancer	3.33e-06	8.61e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	3.33e-06	8.6e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PTEN—pancreatic cancer	3.25e-06	8.39e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PTEN—pancreatic cancer	3.25e-06	8.38e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—PIK3CA—pancreatic cancer	3.17e-06	8.18e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—TYMS—pancreatic cancer	3.1e-06	8.01e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PTEN—pancreatic cancer	3.07e-06	7.91e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	3.06e-06	7.91e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	3.04e-06	7.84e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	2.9e-06	7.49e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PTGS2—pancreatic cancer	2.88e-06	7.43e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	2.67e-06	6.89e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	2.65e-06	6.83e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PTGS2—pancreatic cancer	2.65e-06	6.83e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PTGS2—pancreatic cancer	2.62e-06	6.77e-05	CbGpPWpGaD
Sildenafil—CYP3A7—Metabolism—AKT1—pancreatic cancer	2.59e-06	6.68e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—APOE—pancreatic cancer	2.52e-06	6.52e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PTEN—pancreatic cancer	2.51e-06	6.48e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PTEN—pancreatic cancer	2.31e-06	5.96e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—PIK3CA—pancreatic cancer	2.29e-06	5.92e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—PIK3CA—pancreatic cancer	2.29e-06	5.91e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PTEN—pancreatic cancer	2.29e-06	5.91e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	2.28e-06	5.88e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PPARG—pancreatic cancer	2.2e-06	5.68e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—PIK3CA—pancreatic cancer	2.16e-06	5.58e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	2e-06	5.17e-05	CbGpPWpGaD
Sildenafil—CYP2E1—Metabolism—AKT1—pancreatic cancer	1.87e-06	4.84e-05	CbGpPWpGaD
Sildenafil—CYP3A5—Metabolism—AKT1—pancreatic cancer	1.87e-06	4.83e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	1.77e-06	4.57e-05	CbGpPWpGaD
Sildenafil—CYP1A1—Metabolism—AKT1—pancreatic cancer	1.77e-06	4.56e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.75e-06	4.51e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.73e-06	4.47e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1.63e-06	4.2e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	1.61e-06	4.17e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.51e-06	3.89e-05	CbGpPWpGaD
Sildenafil—CYP2C19—Metabolism—AKT1—pancreatic cancer	1.45e-06	3.73e-05	CbGpPWpGaD
Sildenafil—CYP2D6—Metabolism—AKT1—pancreatic cancer	1.33e-06	3.43e-05	CbGpPWpGaD
Sildenafil—CYP2C9—Metabolism—AKT1—pancreatic cancer	1.32e-06	3.4e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.06e-06	2.75e-05	CbGpPWpGaD
Sildenafil—CYP3A4—Metabolism—AKT1—pancreatic cancer	8.69e-07	2.24e-05	CbGpPWpGaD
